Pradeep Albert, MD

Chief Executive OfficerOfficers & Management Team

Dr. Pradeep Albert is the Chief Executive Officer of Vesalius Longevity Labs, leading the company’s strategy, regulatory alignment, and clinical integrity dedicated to peptide, regenerative, and longevity science. A physician-executive with over 20 years of experience, Dr. Albert brings deep expertise across regenerative medicine, advanced diagnostics, and highly regulated healthcare environments. His background spans clinical practice, healthcare entrepreneurship, and global medical innovation, with a proven ability to translate emerging science into scalable, compliant, and commercially viable platforms. His leadership anchors Vesalius’ institutional-grade standards, ensuring scientific rigor, regulatory discipline, and long-term credibility as the company scales globally.

Back to Leadership

Disclaimer: The information provided on this website is intended for general educational and informational purposes only. Vesalius Longevity Labs provides information relating to peptide science, longevity, wellness, metabolic health, and emerging areas of medical research.

FDA Approval & Investigational Therapies: Not all peptides, compounds, medications, or therapies discussed or referenced on this website are approved by the U.S. Food and Drug Administration (FDA). Certain compounds may be investigational, have limited clinical evidence, or lack established long-term safety and efficacy data. References to scientific research, emerging therapies, or potential health benefits are provided for informational purposes and should not be interpreted as claims of FDA approval, established clinical effectiveness, or guaranteed therapeutic outcomes. Where legally permitted, certain medications may be compounded by appropriately licensed pharmacies in accordance with applicable federal and state laws. Compounded medications are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before marketing in the same manner as FDA-approved medications. Read the full disclaimer.